Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Janz, Martin Dr. (9) Lusatis, Simone (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Specker, Edgar Dr. (1) von Kries, Jens Peter Dr. (1) (-) Mathas, Stephan Dr. (8) (-) Wollert-Wulf, Brigitte (4) (-) Biologie maligner Lymphome (10) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Genomics (1) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Tumorgenetik und zelluläre Stressantworten (1) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (3) 2008 (4) 2009 (3) 2010 (3) 2011 (4) 2012 (1) (-) 2013 (3) 2014 (2) 2015 (5) 2016 (2) (-) 2017 (3) 2018 (1) 2019 (2) 2020 (2) 2021 (3) 2022 (4) 2023 (9) 2024 (1) 10 Ergebnisse: Active Filter: Mathas, Stephan Dr.Wollert-Wulf, BrigitteBiologie maligner Lymphome200620132017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. März 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas 05. Januar 2017 / Blood Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma J. Du M. Neuenschwander Y. Yu J.H.M. Däbritz N.R. Neuendorff K. Schleich A. Bittner M. Milanovic G. Beuster S. Radetzki E. Specker M. Reimann F. Rosenbauer S. Mathas P. Lohneis M. Hummel B. Dörken J.P. von Kries S. Lee C.A. Schmitt 01. Dezember 2017 / Lancet Oncol Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group D.A. Eichenauer A. Plütschow S. Kreissl M. Sökler J.C. Hellmuth J. Meissner S. Mathas M.S. Topp K. Behringer W. Klapper G. Kuhnert M. Dietlein C. Kobe M. Fuchs V. Diehl A. Engert P. Borchmann 02. April 2013 / Structure Structural insights into the mechanism of GTPase activation in the GIMAP family D. Schwefel B.S. Arasu S.F. Marino B. Lamprecht K. Köchert E. Rosenbaum J. Eichhorst B. Wiesner J. Behlke O. Rocks S. Mathas O. Daumke 23. Juli 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz 26. September 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
01. März 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas
05. Januar 2017 / Blood Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma J. Du M. Neuenschwander Y. Yu J.H.M. Däbritz N.R. Neuendorff K. Schleich A. Bittner M. Milanovic G. Beuster S. Radetzki E. Specker M. Reimann F. Rosenbauer S. Mathas P. Lohneis M. Hummel B. Dörken J.P. von Kries S. Lee C.A. Schmitt
01. Dezember 2017 / Lancet Oncol Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group D.A. Eichenauer A. Plütschow S. Kreissl M. Sökler J.C. Hellmuth J. Meissner S. Mathas M.S. Topp K. Behringer W. Klapper G. Kuhnert M. Dietlein C. Kobe M. Fuchs V. Diehl A. Engert P. Borchmann
02. April 2013 / Structure Structural insights into the mechanism of GTPase activation in the GIMAP family D. Schwefel B.S. Arasu S.F. Marino B. Lamprecht K. Köchert E. Rosenbaum J. Eichhorst B. Wiesner J. Behlke O. Rocks S. Mathas O. Daumke
23. Juli 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz
26. September 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken